Knowledge, uptake and therapeutic effectiveness of sulfadoxine-pyrimethamine (IPTp-SP) among pregnant women attending the antenatal clinic at ayeduase Health Centre in Oforikrom Municipality in the Ashanti-region, Ghana

Abstract Background Malaria is a life-threatening disease, and in pregnancy, it has been recognized to pose a substantial threat to mothers, fetuses and neonates and accounted for 249 million malaria cases and 608,000 malaria deaths in 85 countries in 2022. Malaria in pregnancy poses a significant t...

Full description

Bibliographic Details
Published in:	BMC Pregnancy and Childbirth
Main Authors:	Daniel Ansong, David Mensah Otoo, Vivian Mensah
Format:	Article
Language:	English
Published:	BMC 2025-03-01
Subjects:	Knowledge Uptake Therapeutic effectiveness Sulfadoxine-pyrimethamine (IPTp-SP) Pregnant women
Online Access:	https://doi.org/10.1186/s12884-024-07089-4

Similar Items

The Comparative Effects of Antenatal Azithromycin and Sulfadoxine-pyrimethamine on Maternal Malaria during Pregnancy
by: Ganiyu Olanipekun Ahmed, et al.
Published: (2024-10-01)

A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention
by: Thiery Masserey, et al.
Published: (2025-02-01)

Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V
by: Mary C. Oguike, et al.
Published: (2016-12-01)

Evidence on sulfadoxine-pyrimethamine resistance molecular markers from India: interpret with caution
by: Nimita Deora, et al.
Published: (2024-07-01)

Impact of Community Intermittent Preventive Treatment in Pregnancy (C-IPTp) approach on the uptake of IPTp3+: a randomized controlled trial in Karagwe, Tanzania
by: Alen Kinyina, et al.
Published: (2020-12-01)

Factors influencing low coverage of optimal dose of intermittent preventive treatment with sulfadoxine-pyrimethamine among pregnant women in Farafangana, Madagascar, 2024
by: Botovola Miraimila, et al.
Published: (2025-10-01)

Chloroquine and Sulfadoxine–Pyrimethamine Resistance in Sub-Saharan Africa—A Review
by: Alexandra T. Roux, et al.
Published: (2021-06-01)

Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
by: Philippe Deloron, et al.
Published: (2010-11-01)

Profile of molecular markers of Sulfadoxine-Pyrimethamine-resistant Plasmodium falciparum in individuals living in southern area of Brazzaville, Republic of Congo
by: Jean Claude Djontu, et al.
Published: (2024-12-01)

Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling and next-generation sequencing
by: Jeremiah M. Ngondi, et al.
Published: (2017-06-01)

Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to <it>Plasmodium falciparum </it>in Mozambican Children
by: Quelhas Diana, et al.
Published: (2012-01-01)

Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru
by: Alan J. Magill, et al.
Published: (2004-06-01)

Late ANC initiation and factors associated with sub-optimal uptake of sulphadoxine-pyrimethamine in pregnancy: a preliminary study in Cape Coast Metropolis, Ghana
by: Benjamin Kwasi Amoako, et al.
Published: (2021-02-01)

Superiority trial of intermittent treatment with dihydroartemisinin–piperaquine versus sulfadoxine–pyrimethamine for the prevention of malaria during pregnancy
by: Roland Nnaemeka Okoro, et al.
Published: (2023-01-01)

Gametocytaemia in senegalese children with uncomplicated Falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine
by: Sokhina C.S, et al.
Published: (2001-09-01)

Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon
by: Basco Leonardo K., et al.
Published: (2002-01-01)

Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
by: Ashish Pathak, et al.
Published: (2020-08-01)

Disparate co-evolution and prevalence of sulfadoxine and pyrimethamine resistance alleles and haplotypes at dhfr and dhps genes across Africa
by: Nina F. D. White, et al.
Published: (2025-04-01)

Enhancing the uptake of intermittent preventive treatment for malaria in pregnancy: a scoping review of interventions and gender-informed approaches
by: Irene A. Kretchy, et al.
Published: (2025-02-01)

Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial
by: Moussa Lingani, et al.
Published: (2023-03-01)

Making the most of existing antimalarial medicines: a single dose cure with sulfadoxine–pyrimethamine plus artesunate–pyronaridine
by: Ghyslain Mombo-Ngoma, et al.
Published: (2025-09-01)

Effects of antifolates - co-trimoxazole and pyrimethamine-sulfadoxine - on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria
by: A Sowunmi, et al.
Published: (2005-07-01)

Audit of failure rate of sulfadoxine/pyrimetham combined with chloroquine to treat falciparum malaria at single fourteen-day follow-up
by: C.H. Vaughan Williams, et al.
Published: (2002-03-01)

Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan
by: Irene Molina-de la Fuente, et al.
Published: (2023-11-01)

Investigating the dynamics of Plasmodium falciparum gametocyte carriage in expectant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Kilifi, study protocol [version 2; peer review: 3 approved]
by: Isabella Oyier, et al.
Published: (2025-04-01)

Investigating the dynamics of Plasmodium falciparum gametocyte carriage in expectant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Kilifi, study protocol [version 1; peer review: 2 approved]
by: Isabella Oyier, et al.
Published: (2025-03-01)

Projected uptake of sulfadoxine–pyrimethamine for perennial malaria chemoprevention in children under 2 years of age in nine sub-Saharan African countries: an epidemiologically-based 5-year forecast analysis
by: Céline Audibert, et al.
Published: (2025-04-01)

Trends in Molecular Markers Associated with Resistance to Sulfadoxine-Pyrimethamine (SP) Among Plasmodium falciparum Isolates on Bioko Island, Equatorial Guinea: 2011–2017
by: Lin LY, et al.
Published: (2020-04-01)

Direct therapeutic effect of sulfadoxine-pyrimethamine on nutritional deficiency-induced enteric dysfunction in a human Intestine ChipResearch in context
by: Seongmin Kim, et al.
Published: (2024-01-01)

Comparative evaluation of the efficacy of chloroquine and sulphadoxine-pyrimethamine in the treatment of uncomplicated Malaria in children under five years in a Rural population of Enugu State
by: Henrietta U Okafor, et al.
Published: (2004-01-01)

Individual and community-level correlates of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: a multilevel analysis of the 2022 national survey
by: Elihuruma Eliufoo Stephano, et al.
Published: (2025-07-01)

Effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine: An in silico pharmacological model
by: Mila Nu Nu Htay, et al.
Published: (2020-01-01)

Women’s empowerment and uptake of sulfadoxine–pyrimethamine for intermittent preventive treatment of malaria during pregnancy: results from a cross-sectional baseline survey in the Lake endemic region, Kenya
by: George Odwe, et al.
Published: (2023-08-01)

Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo
by: Emrah Ruh, et al.
Published: (2018-01-01)

Experiences of young mothers with the uptake of Sulfadoxine-Pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a cross-sectional study in the Lake endemic region, Kenya
by: Dennis Juma Matanda, et al.
Published: (2024-03-01)

Uptake and Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine during Pregnancy in Africa: A Scoping Review
by: Gifty Osei Berchie, et al.
Published: (2024-09-01)

High Frequency Mutations in pfdhfr and pfdhps of Plasmodium falciparum in Response to Sulfadoxine-Pyrimethamine: A Cross-Sectional Survey in Returning Chinese Migrants From Africa
by: He Yan, et al.
Published: (2021-09-01)

Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine–pyrimethamine five years (2016–2020) after the implementation of seasonal malaria chemoprevention in Cameroon [version 1; peer review: 2 approved, 1 approved with reservations]
by: Palmer M. Netongo, et al.
Published: (2024-06-01)

Sex of household head and trends in uptake of sulfadoxine-pyrimethamine intermittent preventive treatment for malaria during pregnancy: insights from secondary data in sub-Saharan Africa
by: Benjamin Kobina Kwansa, et al.
Published: (2025-03-01)

Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon
by: Judith K. Anchang-Kimbi, et al.
Published: (2020-03-01)